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Implication of Nursing Care
Bipolar Disorder
Heather Guthrie BSN, RN
Introduction Mood Disorder 
Questionnaire 
(MDQ)
The Mood Disorder Questionnaire 
(MDQ) is an established tool utilized 
throughout the medical field.  MDQ was 
developed by a team of psychiatrist and 
researchers to address a critical need for 
timely and accurate diagnosis of bipolar 
disorders (“NIMH bipolar disorder”, 
2020).  This tool is a self-reporting 
questionnaire that focuses on 
recognitions and occurrence of bipolar 
disorder signs.  MDQ is used as an 
clinical and nonclinical psychiatric 
evaluation tool that utilizes all bipolar 
spectrum disorders.   The questionnaire 
utilizes 13 questions regarding mood, 
activity level, and behaviors,  whether 
symptoms occur together, and if 
symptoms cause trouble with everyday 
life.  Scoring include 7 positive answers 
in question , positive answer to question 
2, and a moderate to severe answer to 
question 3 (Dumont et al., 2020).
Bipolar affective disorder (BAD) is a 
mood disorder that causes severe shifts 
in mood, energy, concentration, and 
activities of daily living.  Bipolar used to 
called manic-depressive disorder or 
manic depression (NIMH, 2020).  BAD 
mood swings range from deep, low 
depression to severe euphoric-like mania 
with normal  periods in between.  Some 
patients with BAD experience delusions 
and hallucinations that lead to an 
impairment of the cognitive, behavioral 
and affective bodily functions (de Sousa 
Moura et al., 2019).  
Bipolar disorder is divided into type I 
(BDI), type II (BDII), and cyclothymic 
disorder (cyclothymia) (“NIMH bipolar 
disorder”, 2020).   Type I is characterized 
by mood elevation in a severe and 
persistent manner (mania), and deep 
depression episodes in between with 
normalcy.  Type II is characterized by 
mild elevation of mood (hypomania) that 
the patient might even know something 
is different, and a major depressive 
episode (Moura et al., 2019).  
Cyclothymic disorder is described as 
periods of hypomania with depressive 
symptoms lasting longer than 2 years, 
but meeting the standards of BDII 
(“NIMH bipolar disorder”, 2020).  BDII 
was finally recognized as a “real 
disorder” in 1994 by the Diagnostic and 
Statistical Manual of Mental Disorders 
because mood disorders have a variety of 
symptoms that are not classified within 
certain categories.  Within BDI, every 
system is affected and strained to the 
limits.  While BDII some symptoms are 
more susceptible than others to the 
extreme (Gitlin and Malhi, 2020).
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Conclusion
Neurodevelopment is a vital 
component regarding the inception of 
bipolar disorder.  Studies suggest that 
neurocognitive deficits or dysfunction 
occur during and after the first mood 
episode (Kloiber et al., 2020).  Chronic 
neuroinflammation,, caused by aging, 
traumatic brain injuries, viruses, and 
autoimmunity, are associated with BAD 
(Stgitova et al., 2017).  Dopamine, which 
is referred as the “reward 
neurotransmitter”, regulates behavioral  
activation by increasing or decreasing 
behavioral energy within the body 
(Mansur et al., 2020).
Underlying Pathophysiology
Connected to the Brain
Depression
 Feeling very sad or hopeless
 Talking slowly, forgetfulness, or 
having nothing to say
 No sex drive or inability to 
experience pleasure
 Trouble doing simple tasks
 Not having any energy or restless
 Feeling like you cannot enjoy 
anything
 Trouble concentrating or making 
decisions
 Thinking about death or suicide
(“NIMH bipolar disorder”, 2020)
Mania
 Feeling very high, elated, or irritable 
or touchy
 Elevated or irritated mood
 Loss of appetite
 Increase activity or restlessness
 Feelings of jumpiness or wired
 Racing thoughts or talking fast
 Think like they can do many tasks at 
once
 A decreased need for sleep
 Poor judgement or risky behavior
 Feeling of importance, talented, or 
powerful
(“facts on bipolar disorder and FDA-
approved treatment”, 2017)
Signs and Symptoms
Education is the key to living with bipolar disorder.  The suicide rate with 
bipolar patients are the higher than other psychiatric diagnosis.  Substance abuse 
and other comorbid also impact people living with bipolar disorder (Katz et al., 
2020).  Prejudice and discrimination still occur negatively about mental health 
issues.  Education is the key for the patients, families, care givers, and society to help 
understand and explain to eliminate stigma, fear, and prejudice.  Support networks 
will help minimize caregiver burnout, and promote healthy, safe, and affective 
treatment (Maura et al., 2019).
There are a vast amount of treatment options for patient’s living with bipolar 
disorders.  Some of these options are: lithium (medication most commonly used), 
psychotherapy (“talk therapy”), electroconvulsive therapy (ECT), and transcranial 
magnetic stimulation (TMS).  Since BAD is a life-long illness, managing symptoms 
with continuous treatment is the best option for all patients (“NIMH bipolar 
disorder”, 2020).
The brain changes slightly 
during episodes of mania and 
depression.  Thus, brain 
structure/function differs between 
BDI and BDII.  Cognitive 
impairment has been shown during 
the euthymic periods during 
bipolar.  Frontal lobe thickness has 
a direct correlation with executive 
function (Abe et al., 2018).  
Pathophysiology
The pathophysiology of 
bipolar disorder is widely 
unknown due to no genetic or 
biologic markers being 
identified specifically for 
bipolar.  However, studies have 
shown a familial tendency 
suggests that the correlation 
between a parent with BAD will 
have a higher percentage a child 
that could have BAD.  Also, twins 
have an estimated 85% of 
inheritability of BAD.  Even 
among adoptees with a biologic 
family history correlates to a 
strong incidence of developing 
BAD.  Genetic studies suggest 
that chromosomal and genes are 
related to BAD with a mild or 
moderated effect.  However, 
clinical symptoms have a direct 
link to developmental and 
environmental factors are just 
as important as genetic factors 
(Sigitova et al., 2017).
Proper diagnosis is key to 
help the patients succeed to 
have a safe, healthy life.  Usually, 
diagnosis of BAD is by the 
patient’s symptoms, history, and 
experiences.  Accurate diagnosis 
is vital especially in young 
patients (“NIMH bipolar 
disorder”, 2020).
Bipolar disorder is a life altering diagnosis that not only affect the patient but 
everyone in that person’s life.  Many struggles arise with trying to control 
symptoms so the patient has a quality of life beside a BAD diagnosis.  Treatment 
options are patient specific and many trials might need acquired to find the right 
treatment.   Poor judgement, self-harm, and erratic behavior can increase the risk 
for suicide, substance abuse, and death.  Education is vital to reduce the stigma 
living with a mental health disorder.  Acceptance from the community and 
society has a enormous capacity to encourage honesty with bipolar diagnoses.
